Analgesic efficacy of dexmedetomidine in patients undergoing laparoscopic colorectal cancer surgery
Not Applicable
Not yet recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0006382
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
patient undergoing laparoscopic colorectal cancer surgery between October 2020 and May 2021 in samsung medical center
Exclusion Criteria
emergency surgery, metastatic cancer surgery, open surgery
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method postoperative pain score
- Secondary Outcome Measures
Name Time Method postoperative analgesics consumption
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie dexmedetomidine's analgesic effects in colorectal cancer surgery?
How does dexmedetomidine compare to opioids in postoperative pain management for laparoscopic colorectal cancer surgery?
Are there specific biomarkers that predict analgesic response to dexmedetomidine in colorectal cancer patients?
What are the potential adverse events associated with dexmedetomidine use in laparoscopic colorectal cancer surgery?
What combination therapies or alternative drugs show promise in enhancing postoperative analgesia for colorectal cancer patients?